Rep. Dwight Evans discloses trade(s) in AMT, CVS, INTC, PWR, TMO
Dwight Evans (PA03) disclosed 5 transactions, traded Nov 21 – May 11: 0 purchases and 5 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| May 11 | AMT | American Tower Corporation | Sell | $1,001 - $15,000 | Self |
| May 7 | INTC | PERSHING LLC Intel Corporation | Sell (partial) | $1,001 - $15,000 | Self |
| May 7 | PWR | CETERA Quanta Services, Inc. | Sell (partial) | $1,001 - $15,000 | Self |
| May 7 | TMO | CETERA Thermo Fisher Scientific Inc | Sell (partial) | $1,001 - $15,000 | Self |
| Nov 21 | CVS | CETERA 2000152177 CVS Health Corporation | Sell (partial) | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY DWIGHT EVANS →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. House member has filed required disclosures of stock transactions in five companies spanning healthcare, semiconductors, utilities, and real estate. Congressional stock trading disclosures are public record and tracked by markets observers and governance watchdogs as a window into insider positioning and potential conflicts of interest, though disclosure alone does not indicate impropriety or predict market moves.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Dwight EvansSep 28, 2026Rep. Dwight Evans discloses trade(s) in AMT, CVS, INTC, PWR, TMO ↗
How This Could Play Out — recorded when first flagged, not updated
Resolve
LIKELYThe disclosure remains a routine filing with no follow-up scrutiny or legislative action tied to these holdings, treating it as standard transparency compliance with minimal market relevance.
Left Unattended
LIKELYThese trades continue to circulate in congressional trading databases without triggering media attention, activist pressure, or regulatory review, leaving sector and stock-specific sentiment unaffected by the disclosure itself.
Escalate
UNLIKELYIf subsequent reporting or investigation reveals a pattern of trades preceding legislative action on healthcare, semiconductors, or infrastructure—or conflicts between Evans' committee assignments and his holdings—it could amplify scrutiny of congressional trading practices and create reputational pressure on affected sectors.
SPONSORED
Confidence History
- HIGH CONFIDENCESep 28, 2026 at 12:01 AM
Legally mandated financial disclosure filing -- primary source, not a report about the event